Literature DB >> 29079059

Differential Expression of Long Noncoding RNAs in Normal and Inflamed Human Dental Pulp.

Xin Huang1, Ke Chen2.   

Abstract

INTRODUCTION: Dental pulp inflammation is an excellent model for the interaction between tissue inflammation and regenerative processes. It is worthwhile to better understand molecular signaling of repair and regeneration in inflammatory processes. Emerging evidence suggests that long noncoding RNA (lncRNA) participates in immune system inflammatory processes. Here we investigate the expression of lncRNAs in pulpitis, the inflammation of dental pulp tissue, and identify lncRNAs that possibly participate in inflammation responses and odontogenesis.
METHODS: Integrated comparative lncRNA microarray was used to examine lncRNA and mRNA expression between inflamed and normal human pulp tissue. The differential expression of lncRNAs and mRNAs was then validated by quantitative real-time polymerase chain reaction. A bioinformatics analysis was performed to predict the function of differentially expressed lncRNAs and mRNAs.
RESULTS: Our data indicated 752 lncRNAs were significantly differentially expressed (fold change > 2.0; P < .05) in inflamed pulp tissues compared with normal pulp tissues, including 338 upregulated and 414 downregulated lncRNAs. Among the 646 differentially expressed mRNAs (fold change > 2.0; P < .05), 460 were upregulated, and 186 were downregulated. The differentially downregulated genes are enriched for gene ontology terms related to odontogenesis and cell development in biological processes, whereas the differentially upregulated genes are related to immune and inflammation processes.
CONCLUSIONS: LncRNAs are differentially expressed in inflamed human pulp tissue compared with normal pulp tissue, indicating that lncRNAs may play key roles in pulpitis pathogenesis and development.
Copyright © 2017 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; lncRNA; microarray; odontogenesis; pulpitis

Mesh:

Substances:

Year:  2017        PMID: 29079059     DOI: 10.1016/j.joen.2017.08.022

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  6 in total

1.  The Genetic and Epigenetic Mechanisms Involved in Irreversible Pulp Neural Inflammation.

Authors:  Xiaoxi Xi; Yihong Ma; Yuzhen Xu; Anthony Chukwunonso Ogbuehi; Xiangqiong Liu; Yupei Deng; Junming Xi; Haitong Pan; Qian Lin; Bo Li; Wanchen Ning; Xiao Jiang; Hanluo Li; Simin Li; Xianda Hu
Journal:  Dis Markers       Date:  2021-03-08       Impact factor: 3.434

2.  Identification of Immune-Related lncRNA Regulatory Network in Pulpitis.

Authors:  Jing Du; Liu Liu; Fan Yang; Sha Leng; Lan Zhang; Dingming Huang
Journal:  Dis Markers       Date:  2022-06-06       Impact factor: 3.464

Review 3.  Long non‑coding RNAs are novel players in oral inflammatory disorders, potentially premalignant oral epithelial lesions and oral squamous cell carcinoma (Review).

Authors:  Kaiying Zhang; Wei Qiu; Buling Wu; Fuchun Fang
Journal:  Int J Mol Med       Date:  2020-06-03       Impact factor: 4.101

Review 4.  Epigenetic Approaches to the Treatment of Dental Pulp Inflammation and Repair: Opportunities and Obstacles.

Authors:  Michaela Kearney; Paul R Cooper; Anthony J Smith; Henry F Duncan
Journal:  Front Genet       Date:  2018-08-07       Impact factor: 4.599

5.  Comprehensive analysis of an lncRNA-miRNA-mRNA competing endogenous RNA network in pulpitis.

Authors:  Fangcao Lei; Han Zhang; Xiaoli Xie
Journal:  PeerJ       Date:  2019-06-17       Impact factor: 2.984

6.  Gene expression network analyses during infection with virulent and avirulent Trypanosoma cruzi strains unveil a role for fibroblasts in neutrophil recruitment and activation.

Authors:  Antonio Edson R Oliveira; Milton C A Pereira; Ashton T Belew; Ludmila R P Ferreira; Larissa M N Pereira; Eula G A Neves; Maria do Carmo P Nunes; Barbara A Burleigh; Walderez O Dutra; Najib M El-Sayed; Ricardo T Gazzinelli; Santuza M R Teixeira
Journal:  PLoS Pathog       Date:  2020-08-18       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.